Clinical trial Recruiting at 1 site Interventional Ages 18 and up

A program to help cancer patients quit smoking

Official title: Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type: A Pilot Randomized Control Trial (RCT)

Run by University of Utah · NCT06484179 · Data updated 2026-11-12

This study is testing a special program to help recent cancer patients quit smoking by giving them personalized support based on their type of cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Salt Lake City, Utah)
StatusRecruiting
StartedAugust 28, 2024
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedNovember 26, 2025
Trial IDNCT06484179 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult smokers who have been diagnosed with breast, colorectal, gynecological, skin melanoma, or bladder cancer within the past six months.

Probably not a fit

Patients who are currently enrolled in a smoking cessation program or male patients diagnosed with breast cancer will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research assesses the feasibility and acceptability of a brief self-help intervention designed to enhance motivation for smoking cessation among individuals recently diagnosed with specific types of cancer. The intervention is tailored to the type of cancer the patient has, aiming to provide personalized support. Participants will be compared to a control group receiving usual care to evaluate the effectiveness of the targeted approach. The study will involve individuals who smoke and have received a cancer diagnosis within the last six months.

Why it matters

Potential benefit: If successful, this intervention could significantly increase the motivation and success rates of cancer patients in quitting smoking.

How similar studies have gone: Other studies have shown success with targeted smoking cessation interventions for cancer patients, indicating a promising approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals who smoke and recently (i.e., within 6 months) received a diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer (n = 20 per cancer type). (Investigators will consider smokers individuals who report having smoked ≥1 cigarette in the past 30 days.)
* Able to read/write English;
* Able to give informed consent;
* Not currently enrolled in a smoking cessation program;
* Age ≥18 years old.

Exclusion Criteria:

* Male patients diagnosed with breast cancer will be excluded as lifetime risk for breast cancer in men is far below 1%

Where it's running

  • Huntsman Cancer Institute
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.